# Transcutaneous vagus nerve stimulation reduces total striatal GABA+ content, increases DLPFC Glu content, and facilitates early-phase motor learning

**Authors:** Kana Matsumura, Hiroyuki Matsuta, Ryushin Kawasoe, Tomoyuki Fumuro, Kojiro Matsushita, Nobuhiro Hata, Yoshiki Asayama, Tsuyoshi Shimomura, Minoru Fujiki, Hisato Sugata

PMC · DOI: 10.3389/fnhum.2026.1731345 · Frontiers in Human Neuroscience · 2026-02-18

## TL;DR

Transcutaneous vagus nerve stimulation (tVNS) lowers GABA in the striatum and raises glutamate in the prefrontal cortex, improving early motor learning in healthy adults.

## Contribution

This study provides empirical evidence that tVNS modulates brain neurotransmitter levels and enhances motor learning.

## Key findings

- tVNS significantly reduced GABA+ levels in the left striatum.
- tVNS increased Glu levels in the dorsolateral prefrontal cortex.
- tVNS improved motor task performance in early-phase learning.

## Abstract

Transcutaneous vagus nerve stimulation (tVNS) has emerged as a promising non-invasive technique for modulating neuroplasticity. Previous studies have suggested that changes in regional brain GABA+ signaling contribute to these effects, but empirical neurophysiological evidence remains limited.

We investigated the neurophysiological and behavioral effects of tVNS (200-μs pulses at 20 Hz, alternating 30 s ON–1 s OFF cycles, 30 min total duration) in healthy adults using two experimental paradigms. In Experiment 1, GABA+ and Glutamate (Glu) levels were measured in the left striatum (STR), dorsolateral prefrontal cortex (DLPFC), and sensorimotor cortex (SM) of 34 participants by proton magnetic resonance spectroscopy (1H-MRS), before and after ipsilateral tVNS. In Experiment 2, 27 participants performed a right-hand force-control motor learning task before, during, and after tVNS.

Administration of tVNS significantly reduced GABA+ levels in the left STR (p < 0.05), increased Glu levels in the DLPFC (p < 0.05), and significantly improved motor task performance compared to the sham group at 10 min after stimulus onset (p < 0.05).

tVNS (1) reduced striatal GABA+ levels and increased DLPFC Glu in healthy adults, and (2) facilitated early-phase motor learning. These findings support the use of tVNS as a noninvasive intervention that enhances motor learning in neurorehabilitation and the treatment of motor disorders.

## Full-text entities

- **Genes:** STATH (statherin) [NCBI Gene 6779] {aka STR}, GABARAP (GABA type A receptor-associated protein) [NCBI Gene 11337] {aka ATG8A, GABARAP-a, MM46}
- **Diseases:** Parkinson's disease (MESH:D010300), pain (MESH:D010146), postoperative pain (MESH:D010149), psychiatric (MESH:D001523), stroke (MESH:D020521), resistant epilepsy (MESH:D000069279), PTSD (MESH:D013313), seizure (MESH:D012640), motor deficits (MESH:D009461), epilepsies (MESH:D004827), depression (MESH:D003866), drug (MESH:D000081015), claustrophobia (MESH:D010698), executive dysfunction (MESH:D006331), motor disorders (MESH:D000068079)
- **Chemicals:** oxygen (MESH:D010100), Water (MESH:D014867), Glu (MESH:D018698), GABA (MESH:D005680), 1H (-), proton (MESH:D011522)
- **Species:** Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12957156/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12957156/full.md

## References

84 references — full list in the complete paper: https://tomesphere.com/paper/PMC12957156/full.md

---
Source: https://tomesphere.com/paper/PMC12957156